Federal Health officials are now probing if the Moderna vaccine leads to a higher risk of heart inflammation in young adults.
Federal health officials are conducting an investigation into the effects of the Moderna COVID-19 vaccine following new research that showed it may be linked to a higher risk of heart inflamation in young adults than previously though, according to a report from The Washington Post.
Two people familiar with the review told the Post that the heart condition, called myocarditis, is likely still extremely rare, but added that the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are looking into new Canadian data suggesting a greater risk among a specific demographic that have received the Moderna vaccine
The sources, who spoke on the condition of anonymity, said that the research shows a potentially greater risk of heart inflammation among Moderna than Pfizer-BioNTech recipients, most notably for men age under the age of 30.
The FDA in June added a warning label to the two mRNA vaccines about the potential increased risk of myocarditis, though the CDC, Department of Health and Human Services (HHS) and 15 of leading national medical and public health organizations said in a joint statement that the risk of heart inflammation was much greater among people infected with COVID-19.
Now, we have this.
Moderna’s stock fell.
JUST IN – Moderna stock falls pre-market on reports of U.S. probe into #COVID19 vaccine for higher heart inflammation risk among young adults (WSJ)
— Disclose.tv (@disclosetv) August 20, 2021
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri four years ago at the age of 19. Since its founding, it has gotten over 2M pages views and over 20k followers. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.